Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes

Due to fixed dosing of direct oral anticoagulants (DOACs), uncertainty exists about their efficacy in a population of obese/overweight patients.

Source: International Journal of Cardiology - October 28, 2019 Category: Cardiology Authors: Marko Lucijanic, Ivana Jurin, Hrvoje Jurin, Tomo Lucijanic, Boris Starcevic, Marko Skelin, Anton Glasnovic, Jasmina Catic, Andjela Jurisic, Irzal Hadzibegovic Source Type: research